Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 6 (June)

1. Cancer chemopreventive effects of Pinus Maritima bark extract on ultraviolet radiation and ultraviolet radiation-7,12,dimethylbenz(a)anthracene induced skin carcinogenesis of hairless mice.
   Cancer Lett, 237(2): 234-41. [Abstract] [Full-text]
2. Primary CD20+CD10+CD8+ T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement.
   Am J Clin Pathol, 126(1): 14-22. [Abstract] [Full-text]
3. Thyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides.
   J Clin Endocrinol Metab, 91(6): 2205-8. [Abstract] [Full-text]
4. Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector.
   Int J Cancer, 119(5): 1194-207. [Abstract] [Full-text]
5. Public awareness regarding UV risks and vitamin D--the challenges for UK skin cancer prevention campaigns.
   Prog Biophys Mol Biol, 92(1): 161-6. [Abstract] [Full-text]
6. Initial studies on an in vivo action spectrum for melanoma induction.
   Prog Biophys Mol Biol, 92(1): 97-104. [Abstract] [Full-text]
7. Long-term health risk to the skin of ultraviolet radiation.
   Prog Biophys Mol Biol, 92(1): 92-6. [Abstract] [Full-text]
8. The challenge resulting from positive and negative effects of sunlight: how much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer?
   Prog Biophys Mol Biol, 92(1): 9-16. [Abstract] [Full-text]
9. Acute effects of UVR on human eyes and skin.
   Prog Biophys Mol Biol, 92(1): 80-5. [Abstract] [Full-text]
10. Effectiveness of information campaigns.
    Prog Biophys Mol Biol, 92(1): 167-72. [Abstract] [Full-text]
11. Risks and benefits of sun exposure: implications for public health practice based on the Australian experience.
    Prog Biophys Mol Biol, 92(1): 173-8. [Abstract] [Full-text]
12. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases.
    Int J Cancer, 119(2): 380-4. [Abstract] [Full-text]
13. Value of sentinel node status as a prognostic factor in melanoma: prospective observational study.
    BMJ, 332(7555): 1423. [Abstract] [Full-text]
14. MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas.
    J Invest Dermatol, 126(7): 1510-7. [Abstract] [Full-text]
15. The epidemiology of nevi and signs of skin aging in the adult general population: Results of the KORA-survey 2000.
    J Invest Dermatol, 126(7): 1490-6. [Abstract] [Full-text]
16. The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway.
    J Invest Dermatol, 126(7): 1641-7. [Abstract] [Full-text]
17. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
    J Clin Oncol, 24(18): 2858-65. [Abstract] [Full-text]
18. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
    J Clin Oncol, 24(18): 2849-57. [Abstract] [Full-text]
19. In vivo confocal scanning laser microscopy of benign lentigines: comparison to conventional histology and in vivo characteristics of lentigo maligna.
    J Am Acad Dermatol, 55(1): 88-97. [Abstract] [Full-text]
20. Association between dietary fat and skin cancer in an Australian population using case-control and cohort study designs.
    BMC Cancer, 6: 141. [Abstract] [Full-text]
21. The significance of cutaneous spider naevi in children.
    Arch Dis Child, 91(7): 604-5. [Abstract] [Full-text]
22. Anatomic site, sun exposure, and risk of cutaneous melanoma.
    J Clin Oncol, 24(19): 3172-7. [Abstract] [Full-text]
23. Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses.
    J Clin Oncol, 24(19): 3164-71. [Abstract] [Full-text]
24. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
    J Clin Oncol, 24(19): 3157-63. [Abstract] [Full-text]

© 2004-2012 Skin Cancer Research Today. All Rights Reserved.